source
- Biotech executive Steven Quay dropped from consideration for NIAID director roleSteven Quay, a biotech executive known for promoting the lab‑leak theory, was reportedly in the running to lead the National Institute for Allergy and Infectious Diseases. A source familiar with t…
- Curium lists Bexlutry at $63,524 per infusion, roughly 5% cheaper than Novartis' LutatheraCurium announced the list price for its radioligand Bexlutry, a generic version of Novartis' Lutathera. The price is set at $63,524 per infusion, which represents about a five percent discount com…